European Clinical Quality Oversight Forum London, England, UK 7-8 February 2017

Description:
Following seven years of success and growth in the US and responding to continued requests, ExL is bringing our Clinical Quality Oversight Forum to Europe. With a broader scope than ever before, the CQOF focuses on ensuring trial integrity by effectively assessing, optimizing and managing the quality of clinical vendors and sites.

This forum has earned a reputation for being the annual gathering for clinical quality, operations, management and audit professionals to engage and candidly share their experiences, struggles, obstacles and achievements when working with varying clinical partners, including CROs and investigator sites. Learn from this experienced group and take away proven, results-driven, risk-based strategies for optimizing your company’s clinical vendor and site oversight approach.

Prices:
Conference - Before Early Bird (1/6/2017): GBP 1295,
Conference and Workshop - Before Early Bird (1/6/2017): GBP 1495,
Conference - After Early Bird: GBP 1395,
Conference and Workshop - After Early Bird: GBP 1595

Speakers: Susan Callery-D'Amico, Muriel Cottard, Jeannette Dixon, Joy Eldridge, David William Fryrear, Karen Hue, Tipsuda Kongtong, Milind Nadgouda, Balall Naeem, Patricia Pengelly, Kevin Robinson, Jonathan Rowe, Paul Strickland, Michele Weitz, AbbVie, AstraZeneca, Biogen, Clovis Oncology, Eisai, GlaxoSmithKline, Intercept Pharmaceuticals, MHRA, Novartis, Pfizer, RiverArk, Strickland Quality Assurance